altRx vs Willow: GLP-1 Cost & Plans Compared
altRx vs Willow compared on price, medication format and commitment terms. See which GLP-1 programme fits, and what each actually costs over a year.
Quick Verdict
Editorial Take
Best Overall: Neither can be called the overall winner from published information. altRx publishes semaglutide at $89/month. Willow does not publish a headline monthly rate, so its cost cannot be compared until you complete intake — which is itself worth knowing before you start.
Best for Budget: Not determinable in advance. altRx publishes semaglutide at $89/month. Willow does not publish a headline monthly rate, so its cost cannot be compared until you complete intake — which is itself worth knowing before you start.
Best for Fast Approval: Both run fully online intake with licensed clinician review, so approval speed is unlikely to separate them. altRx quotes shipping as free, discreet, 2 days; Willow quotes free, discreet, 2 days.
At a Glance Comparison
| Feature | altRx | Willow |
|---|---|---|
| Semaglutide price | $89/month | Not published before intake |
| Tirzepatide price | $149/month | Not published before intake |
| Needle-free oral option | No | Yes |
| Brand-name medication | No | No |
| Insurance support | No | No |
| Shipping | Free, discreet, 2 days | Free, discreet, 2 days |
Who Should Choose altRx
Choose altRx if:
- ✓You want itemised supplies and a named clinical group, CareValidate Health, plus buy-now-pay-later
- ✓You are comparing on a published semaglutide rate of $89/month
- ✓You accept the trade-off that its lowest rates require paying 6 or 12 months upfront
Who Should Choose Willow
Choose Willow if:
- ✓You want four formats — semaglutide and tirzepatide, each as a weekly injection or a daily needle-free tablet
- ✓You are comfortable getting a quote at intake rather than shopping on a published price
- ✓You want a needle-free oral option
- ✓You accept the trade-off that cash-pay only and unavailable in 18 states
altRx Deep Dive
altRx leads with itemised supplies and a named clinical group, CareValidate Health, plus buy-now-pay-later. Semaglutide is published at $89/month, tirzepatide at $149/month. The honest caveat is that its lowest rates require paying 6 or 12 months upfront.
How It Works
- Complete the online intake covering health history and weight goals
- A licensed clinician reviews your information and prescribes if appropriate
- Medication ships — free, discreet, 2 days
- Continue with clinician support for dose adjustment
Medications Offered
- ✓Semaglutide from $89/month
- ✓Tirzepatide from $149/month
Pricing
$89/month semaglutide, though prepaid plans lower it to $75/month semaglutide or $125/month tirzepatide at twelve months. Free, discreet, 2 days.
- ✓Itemised supplies and a named clinical group, CareValidate Health, plus buy-now-pay-later
- ✓Free, discreet, 2 days
- ✗Its lowest rates require paying 6 or 12 months upfront
- ✗Compounded medication is not an FDA-approved finished product
Willow Deep Dive
Willow leads with four formats — semaglutide and tirzepatide, each as a weekly injection or a daily needle-free tablet. It does not publish a headline monthly rate ahead of intake. The honest caveat is that cash-pay only and unavailable in 18 states.
How It Works
- Complete the online intake covering health history and weight goals
- A licensed clinician reviews your information and prescribes if appropriate
- Medication ships — free, discreet, 2 days
- Continue with clinician support for dose adjustment
Medications Offered
- ✓Semaglutide, pricing quoted at intake
- ✓Needle-free oral tablet option
Pricing
Pricing quoted at intake. Free, discreet, 2 days.
- ✓Four formats — semaglutide and tirzepatide, each as a weekly injection or a daily needle-free tablet
- ✓Free, discreet, 2 days
- ✓Needle-free oral option available
- ✗Cash-pay only and unavailable in 18 states
- ✗Compounded medication is not an FDA-approved finished product
Honest Tradeoffs
Pricing
altRx publishes semaglutide at $89/month. Willow does not publish a headline monthly rate, so its cost cannot be compared until you complete intake — which is itself worth knowing before you start.
Medication Types
Both dispense compounded semaglutide or tirzepatide. Neither is an FDA-approved finished product, and neither has independent trial evidence for its specific formulation, though both use the same active ingredients as the branded medications.
Doctor Involvement
Both require review by a licensed U.S. clinician before dispensing, and neither is a subscribe-and-ship product. Ongoing support for dose titration is included at both.
Delivery Speed
altRx: Free, discreet, 2 days. Willow: Free, discreet, 2 days. In practice the gap between clinician review times usually matters more than the shipping estimate.
Subscription Model
altRx's advertised rate is conditional — prepaid plans lower it to $75/month semaglutide or $125/month tirzepatide at twelve months — whereas Willow's published rate does not require a prepaid term. Weigh the committed price against the flexible one.
Pricing Breakdown
| Aspect | altRx | Willow |
|---|---|---|
| Semaglutide, monthly | $89/month | Not published before intake |
| Tirzepatide, monthly | $149/month | Not published before intake |
| 6-month semaglutide total | $534 | Not computable from published pricing |
| 12-month semaglutide total | $1,068 | Not computable from published pricing |
| Commitment required for best rate | Yes | No |
What You Actually Pay Over 12 Months
Advertised starting prices are the least useful number in this comparison, so below is what each provider costs across a realistic course of treatment rather than on day one. Pricing verified July 30, 2026; confirm the final figure at enrollment, as offers change.
| altRx | Willow | |
|---|---|---|
| First month | $89/month | Not published before intake |
| 6-month total | $534 | Not computable from published pricing |
| 12-month total | $1,068 | Not computable from published pricing |
| Price includes | Medication, clinician review and ongoing dose support. Shipping: free, discreet, 2 days. | Medication, clinician review and ongoing dose support. Shipping: free, discreet, 2 days. |
| What can raise it | The advertised rate is conditional — prepaid plans lower it to $75/month semaglutide or $125/month tirzepatide at twelve months. | No prepaid term is required to reach the advertised rate. |
altRx publishes semaglutide at $89/month. Willow does not publish a headline monthly rate, so its cost cannot be compared until you complete intake — which is itself worth knowing before you start. altRx's advertised rate is conditional — prepaid plans lower it to $75/month semaglutide or $125/month tirzepatide at twelve months — whereas Willow's published rate does not require a prepaid term. Weigh the committed price against the flexible one. Both dispense compounded semaglutide or tirzepatide. Neither is an FDA-approved finished product, and neither has independent trial evidence for its specific formulation, though both use the same active ingredients as the branded medications.
Medication Comparison
Semaglutide
altRx publishes semaglutide at $89/month. Willow does not publish a headline monthly rate, so its cost cannot be compared until you complete intake — which is itself worth knowing before you start.
Tirzepatide
Tirzepatide pricing is not published by both providers, so the dual-agonist comparison cannot be made from public information. Ask at intake if tirzepatide is what you want.
Which Provider Offers What
Willow offers a needle-free oral option; altRx is injection-only. Both dispense compounded semaglutide or tirzepatide. Neither is an FDA-approved finished product, and neither has independent trial evidence for its specific formulation, though both use the same active ingredients as the branded medications.
Results Expectations
Safety Considerations
Side Effects
Both carry the GLP-1 side-effect profile: nausea, vomiting, diarrhoea, constipation and abdominal discomfort, typically dose-related and most pronounced during titration. GLP-1 medications carry serious warnings including the risk of thyroid C-cell tumours and should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Disclose your full history at intake.
Doctor Supervision
Both require review by a licensed U.S. clinician before dispensing and provide ongoing support for dose adjustment.
Prescription Requirement
Both dispense compounded semaglutide or tirzepatide. Neither is an FDA-approved finished product, and neither has independent trial evidence for its specific formulation, though both use the same active ingredients as the branded medications.
How We Evaluated These Providers
We evaluated both providers based on the following criteria:
- ✓Published monthly pricing for each molecule, and the six and twelve-month totals that follow from it
- ✓Whether the advertised rate requires a prepaid term
- ✓Medication formats offered, including any needle-free option
- ✓Regulatory status: compounded against FDA-approved brand-name
- ✓Whether insurance can be used at all
- ✓Shipping as published by each provider
Final Verdict
Editorial Take
Best for Budget Users
Not determinable from published pricing. altRx publishes semaglutide at $89/month. Willow does not publish a headline monthly rate, so its cost cannot be compared until you complete intake — which is itself worth knowing before you start.
Best for Fast Results
Tied, and neither should claim otherwise. Same molecules, comparable clinician-led process; the pace of results depends on titration and adherence rather than the provider.
Best for Doctor Supervision
Comparable. Both require licensed clinician review before dispensing and include ongoing dose support.
Best Premium Experience
altRx for itemised supplies and a named clinical group, CareValidate Health, plus buy-now-pay-later; Willow for four formats — semaglutide and tirzepatide, each as a weekly injection or a daily needle-free tablet. Which reads as premium depends on whether you value the programme around the medication or the lowest number on the invoice.
Frequently Asked Questions
Read Our Full Reviews
Related Comparisons
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.